february 9, 2024
U.S. Fertility Market Size if Expanding USD 8.69 Billion By 2033
The U.S. fertility market size accounted for USD 5.34 billion in 2023 and is expanding to around USD 8.69 billion by 2033 with a registered CAGR of 4.78% from 2024 to 2033.
Infertility Evaluation and Treatment among Women in the United States
More than 40% of couples who seek infertility evaluation do not pursue treatment. Given the substantial financial, physical, and psychological burdens of first pursing an evaluation and then pursuing treatments that could be futile, it may be short-sighted to limit a patient’s access to only those infertility treatments that are affordable to the patient or are covered by insurance.
October, 2013
The mismatch in supply and demand: reproductive endocrinology and infertility workforce challenges and controversies
At present, there is a large mismatch in supply and demand, and the need for more REI fellowship-trained physicians is one of the greatest challenges that the field faces. Collaborations with obstetricians or gynecologists (Ob/Gyns) and women’s health clinics; the use of physician extenders, such as advanced practice providers; and leveraging technology are varied strategies to expand access to care.
september, 2023
Should IUI replace IVF as first-line treatment for unexplained infertility? A literature review
Unexplained infertility accounts for 25% of infertility causes in the UK. This review aims to provide a literature overview exploring whether IUI or IVF should be used as first-line treatment for couples with unexplained infertility.
October 27, 2023
Meeting the demand for fertility services: the present and future of reproductive endocrinology and infertility in the United States
The WHO and American Medical Association have established that infertility care is a basic human right but unfortunately this remains aspirational for many if not most patients. There is now an opportunity to expand access to high-quality care by harnessing our knowledge and scaling it to meet the demand.
October, 2023
Impact of in vitro fertilization state mandates for third party insurance coverage in the United States: a review and critical assessment
The American Society for Reproductive Medicine estimates that fewer than a quarter of infertile couples have sufficient access to infertility care. Insurers in the United States (US) have long considered infertility to be a socially constructed condition, and thus in-vitro fertilization (IVF) an elective intervention. As a result, IVF is cost prohibitive for many patients in the US.
August 4, 2022
2019 OB-GYN Workforce Study:
Physician Shortages Contribute to Women’s Health Crisis
An increase in retiring OB-GYNs could cause workforce shortages, making it difficult to keep up with the demand for women’s health care services nationwide. OB-GYNs continue to face high workload demands and compensation issues that are potentially contributing to a national shortage.
september 2019
Intrauterine Insemination (IUI) Patient Fact Sheet
This fact sheet developed by the American Society for Reproductive Medicine reviews IUI as a method of addressing infertility. Click below to learn what IUI is, how it is done, risks, benefits, and effectiveness, and other considerations of the procedure.
2021
Collecting Semen Samples At Home For IVF/ICSI Does Not Negatively Affect The Outcome Of The Fresh Cycle
Collecting semen samples at home has a positive effect on sperm quality (sperm concentration and motility were higher), but no significant differences in cycle outcomes are observed when these samples are used in IVF/ICSI cycles. Therefore, it is suggested that collecting semen samples at home for IVF/ICSI procedures is safe and has no negative effect on treatment outcomes.
FEBRUARY 2021
Comparison of Semen Parameters In Samples Collected By Masturbation At A Clinic and At Home
The present results demonstrate superior semen quality in samples collected by masturbation at home compared with at a clinic. This should be taken into consideration in infertility investigations.
